+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan



Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan



Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 97(7): 815-822



To assess the safety and efficacy of photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia (BPH). Fifty-seven patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia underwent 80 W KTP laser vaporization of the prostate. According to their International Prostate Symptom Score Index (IPSS) and Quality of life (QOL) score as well as measurements of their peak flow rate and postvoiding residual urine volume (RUV), they fulfilled the diagnostic criteria of BPH. Vaporization was performed with the GreenLight PV ADDStat fiber, which was inserted through a 22.5Fr. continuous flow laser cystoscope, and a saline solution was used for irrigation. KTP laser energy was generated by a GreenLight PV (Minnetonka, Minnesota) generator. The end point of the procedure was to create a cavity like in TURP. Once vaporization was completed, an18Fr Foley catheter was inserted and was removed the next morning, as a rule. Patients were evaluated preoperatively, and at 2 weeks and 1, 3 and 6 months postoperatively. The procedure could be performed without any intraoperative complication. None of the patients required continuous bladder irrigation or blood transfusion postoperatively. The mean age was 71.0 +/- 8.3 years (range 52 to 86). The preoperative prostate volume was 41.0 +/- 24.9 (mean +/- SD, range 6.7 to 107.2) and the preoperative serum PSA was 4.5 +/- 4.1 ng/ml. Preoperative and immediate postoperative serum sodium concentration was 141.9 +/- 1.8 mEq/L and 142.2 +/- 1.8 mEq/L, respectively (p = 0.23). The hemoglobin value changed from 14.0 +/- 1.4 mg/dl preoperatively to 13.4 +/- 1.4 mg/dl postoperatively. The operating time was 68.3 +/- 35.0 minutes (range 21 to 170) and total laser energy was 171.1 +/- 80.3 kJ (range 18.1 to 484.8). The catheter indwelling time was 18.6 +/- 3.3 hrs (range 15 to 48). At 2 weeks and 1, 3 and 6 months the International Prostate Symptom Score decreased from 20.2 +/- 8.9 to 11.4 +/- 7.8, 9.3 +/- 6.0, 6.6 +/- 5.0 and 6.1 +/- 5.0, respectively. The maximum urinary flow increased from 7.2 +/- 2.9 mL/s to 13.6 +/- 7.6, 12.2 +/- 6.1, 15.3 +/- 7.4, and 15.3 +/- 7.5 mL/s, respectively. Photoselective vaporization of the prostate (PVP) using the high power (80 W) potassium-titanyl-phosphate laser for benign prostatic hyperplasia (BPH) proved to be an effective and safe procedure for our patients.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049918373

Download citation: RISBibTeXText

PMID: 17154023


Related references

Photoselective Vaporization Of The Prostate (Pvp) Using 80 Watt High Power Potassium-Titanyl-Phosphate (Ktp) Laser For Benign Prostatic Hyperplasia. The Japanese Journal of Urology 97(7): 815-822, 2006

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 64(6): 1155-1159, 2004

High-power potassium-titanyl-phosphate laser photoselective vaporization prostatectomy for symptomatic benign prostatic hyperplasia. Journal of Endourology 22(6): 1311-1314, 2008

High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. Journal of Endourology 21(10): 1141-1144, 2007

Safety and efficacy of the potassium-titanyl-phosphate laser and photoselective vaporization of the prostate for benign prostatic hyperplasia. Reviews in Urology 8(Suppl. 3): S16-S23, 2006

The Efficacy and Safety of Photoselective Vaporization of the Prostate with a Potassium-titanyl-phosphate Laser for Symptomatic Benign Prostatic Hyperplasia according to Prostate Size: 2-Year Surgical Outcomes. Korean Journal of Urology 51(5): 330-336, 2010

Potassium-titanyl-phosphate (KTP)/lithium triboride (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH): A systematic approach. 2007

Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. Journal of Endourology 26(7): 878-883, 2012

Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. Journal of Urology 174(4 Pt 1): 1344-1348, 2005

Photoselective Potassium-Titanyl-Phosphate Laser Vaporization of the Benign Obstructive Prostate: Observations on Long-Term Outcomes. Yearbook of Urology 2006: 122-123, 2006

Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser. Wiadomosci Lekarskie 59(3-4): 196-198, 2006

High-power KTP photoselective laser vaporization prostatectomy versus transurethral electrovaporization of the prostate for the treatment of benign prostatic hyperplasia A prospective comparative trial. Journal of Urology 171(4 Suppl.): 402, 2004

Comparative Evaluation Of High Power 532nm Laser Systems, 120 Watt (Hps) Vs 80 Watt (Ktp), For Photoselective Vaporization Of The Prostate (Pvp) Of Large Glands With Vaporization Incision Technique (Vit). The Journal of Urology 179(4): 626-627, 2008

Comparison of vaporization efficiency of the 80W potassium-titanyl-phosphate (KTP) greenlight (TM) laser and the 120W greenlight high performance system (HPS) laser for photoselective vaporization of the prostate. The Journal of Urology 179(4): 626, 2008

High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure?. Bju International 107(12): 1938-1942, 2011